SUSMED
Digital Therapeutics and Therapeutics Management System.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | N/A | IPO | |
| Total Funding | 000k | ||
| JPY | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 231 % | 174 % | 67 % | (35 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (438 %) | (285 %) | (67 %) | (7 %) | (105 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (278 %) | (240 %) | (74 %) | (10 %) | (104 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 248 % | 216 % | 71 % | 33 % | 71 % |
Source: Company filings or news article
Related Content
Susmed Inc. operates in the healthcare and pharmaceutical sectors, focusing on providing advanced clinical trial solutions. The company leverages cutting-edge technologies such as blockchain and artificial intelligence (AI) to enhance the efficiency and reliability of clinical trials. Their primary clients include pharmaceutical companies, hospitals, academic institutions, and health insurance providers. Susmed's business model revolves around offering a comprehensive platform that integrates clinical development systems, enabling seamless monitoring and data management for clinical trials. The company generates revenue through service fees and subscription models for their platform. By streamlining the clinical trial process, Susmed aims to accelerate the approval of medical equipment and pharmaceuticals, ultimately contributing to improved healthcare outcomes.
Keywords: clinical trials, blockchain, AI, pharmaceuticals, healthcare, data management, hospitals, academic institutions, health insurance, medical equipment.